Search Results - "VIEGAS, T. X"
-
1
Pharmacokinetics and Pharmacodynamics of Peldesine (BCX-34), a Purine Nucleoside Phosphorylase Inhibitor, following Single and Multiple Oral Doses in Healthy Volunteers
Published in Journal of clinical pharmacology (01-04-2000)“…The pharmacokinetic parameters of peldesine (BCX‐34) were investigated after single and multiple oral doses in two groups of healthy adult volunteers. The…”
Get full text
Journal Article -
2
Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules
Published in International journal of pharmaceutics (01-03-1999)“…Danazol was dissolved in non-aqueous mixtures containing either polyethylene glycol 400 or polysorbate 80, and filled into hard gelatin capsules at 50 mg…”
Get full text
Journal Article -
3
Evaluation of creams and ointments as suitable formulations for peldesine
Published in International journal of pharmaceutics (21-05-2001)“…In-vitro studies were conducted to study the efficacy of mixed and self-emulsifying creams and hydrophobic ointment formulations in delivering peldesine…”
Get full text
Journal Article -
4
Osmotic behavior of poloxamer 407 and other non-ionic surfactants in aqueous solutions
Published in International journal of pharmaceutics (26-01-1998)“…Solutions of non-ionic surfactants were prepared in water and buffer. The osmotic behavior of these solutions were studied by measuring their osmolality, using…”
Get full text
Journal Article -
5
Percutaneous absorption of bendroflumethiazide from gel and membrane-controlled gel systems: an in vitro and in vivo study
Published in International journal of pharmaceutics (26-06-1997)“…A number of gel formulations were developed for bendroflumethiazide (BFTZ). The gels were composed of BFTZ dissolved in an alcohol–polyol–water medium and…”
Get full text
Journal Article -
6
Preformulation studies for the development of a parenteral liquid formulation of the immunomodulator, peldesine
Published in PDA journal of pharmaceutical science and technology (01-11-1999)“…Peldesine (BCX-34) is a potent inhibitor of the enzyme purine nucleoside phosphorylase (PNP). The object of this study was to determine the preformulation…”
Get more information
Journal Article -
7
An in vitro method of evaluating tolnaftate release from topical powder
Published in Pharmaceutical research (01-04-1986)“…A dissolution apparatus was constructed to evaluate tolnaftate release from topical powders. It consisted of a mesh unit to support the powder, a receptor…”
Get full text
Journal Article